Microbial natural product biosynthesis focuses on the production of bioactive compounds (e.g., antibiotics, antitumor agents) through microbial secondary metabolic pathways. It involves elucidating synthetic gene clusters, enzymatic mechanisms, and regulatory networks to discover novel compounds and optimize production strategies, supporting drug development and industrial biomanufacturing.